Special paperMobilization of heavy metals by newer, therapeutically useful chelating agents
References (62)
- et al.
Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid
Life Sci.
(1982) - et al.
DMSA, DMPS and DMPA-as arsenic antidotes
Fund. Appl. Toxicol.
(1984) - et al.
Treatment of lead poisoning by 2,3-dimercaptosuccinic acid
Lancet
(1978) - et al.
Dose response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations
J. Pediatr.
(1988) - et al.
BAL increases the arsenic-74 content of rabbit brain
Toxicol. Appl. Pharmacol.
(1983) - et al.
The search for chelate antagonists for chronic cadmium intoxication
Toxicology
(1990) - et al.
Fluorometric determination of 2,3-dimercapto-1-sulfonic acid and other dithiols by precolumn derivatization with bromobimane and column liquid chromatography
J. Chromatogr.
(1986) - et al.
Determination and metabolism of dithiol chelating agents: electrolytic and chemical reduction of oxidized dithiols in urine
Anal. Biochem.
(1987) - et al.
Determination and metabolism of dithiol chelating agents: VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with l-cysteine in human urine
Toxicol. Appl. Pharmacol.
(1989) Childhood lead poisoning: definitions and priorities
Pediatrics
(1993)
Radioactive compounds excreted by rats treated with 35S-labelled. British anti-lewisite; Preliminary studies
Biochem. J.
(1955)
Childhood lead poisoning and its treatment
Annu. Rev. Pharmacol. Toxicol.
(1993)
DMSA and DMPS-water soluble antidotes for heavy metal poisoning
Annu. Rev. Pharmacol. Toxicol.
(1983)
Urinary excretion of meso-dimercaptosuccinic acid in human subjects
Clin. Pharmacol. Therap.
(1989)
Meso-2,3-dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent
Annu. Rev. Pharmacol. Toxicol.
(1990)
Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score
FASEB. J.
(1992)
Human studies with the chelating agents, DMPS and DMSA
Clin. Toxicol.
(1992)
Retention of lead in the rat
Arch. Environ. Contain. Toxicol.
(1985)
Accelerated uptake of mercury by brain caused by 2,3-dimercaptopropanol (BAL) after injection into the mouse of methylmercuric compound
Acta Pharmacol. Toxicol.
(1965)
Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in choralkali plant workers: Part I: History, neuropsychological findings and chelator effects
Human Exp. Toxicol.
(1992)
The therapeutic use of 2,3-dimercaptopropane-1-sulfonate in two cases of inorganic mercury poisoning
JAMA
(1986)
Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate
J. Pharmacol. Exp. Therap.
(1988)
Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children
J. Pharmacol. Exp. Therap.
(1985)
Mobilization of lead by calcium disodium edetate; a reappraisal (editorial)
Am. J. Dis. Child.
(1987)
Tests of efficacy of antidotes for removal of methyl mercury in human poisoning during the Iraq outbreak
J. Pharmacol. Exp. Therap.
(1981)
The prediction of intake of mercury vapor from amalgams
Mercury — an element of mystery
N. Engl. J. Med.
(1990)
Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy
J. Pharmacol. Exp. Therap.
(1987)
Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy
J. Pharmacol. Exp. Therap.
(1988)
Zur Therapie quecksilberinduzierter Organschäden
Z. Gesamte Inn. Med.
(1990)
Antidotal effects of dimercaptosuccinic acid
J. Appl. Toxicol.
(1991)
Cited by (0)
Copyright © 1995 Published by Elsevier Ireland Ltd.